- Home
- ARTW vs APVO Comparison
ARTW vs APVO Comparison
Compare ARTW & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- APVO
- Stock Information
- Founded
- ARTW 1956
- APVO 2016
- Country
- ARTW United States
- APVO United States
- Employees
- ARTW N/A
- APVO N/A
- Industry
- ARTW Industrial Machinery/Components
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- ARTW Industrials
- APVO Health Care
- Exchange
- ARTW Nasdaq
- APVO Nasdaq
- Market Cap
- ARTW 7.8M
- APVO 6.5M
- IPO Year
- ARTW N/A
- APVO N/A
- Fundamental
- Price
- ARTW $1.81
- APVO $4.46
- Analyst Decision
- ARTW
- APVO Strong Buy
- Analyst Count
- ARTW 0
- APVO 1
- Target Price
- ARTW N/A
- APVO $296.00
- AVG Volume (30 Days)
- ARTW 633.7K
- APVO 90.6K
- Earning Date
- ARTW 02-26-2025
- APVO 03-04-2025
- Dividend Yield
- ARTW N/A
- APVO N/A
- EPS Growth
- ARTW N/A
- APVO N/A
- EPS
- ARTW N/A
- APVO N/A
- Revenue
- ARTW $25,181,639.00
- APVO N/A
- Revenue This Year
- ARTW N/A
- APVO N/A
- Revenue Next Year
- ARTW N/A
- APVO N/A
- P/E Ratio
- ARTW N/A
- APVO N/A
- Revenue Growth
- ARTW N/A
- APVO N/A
- 52 Week Low
- ARTW $1.33
- APVO $3.65
- 52 Week High
- ARTW $4.15
- APVO $399.60
- Technical
- Relative Strength Index (RSI)
- ARTW 49.49
- APVO 38.21
- Support Level
- ARTW $1.60
- APVO $4.32
- Resistance Level
- ARTW $2.21
- APVO $4.79
- Average True Range (ATR)
- ARTW 0.41
- APVO 0.45
- MACD
- ARTW -0.05
- APVO 0.15
- Stochastic Oscillator
- ARTW 8.24
- APVO 19.53
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world-wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.